The prognostic value of survivin expression in patients with colorectal carcinoma: A meta-analysis

Japanese Journal of Clinical Oncology

Volumn 43, Issue 10, 2013, Pages 988-995

  Huang, Yu Jing ^a   Qi, Wei Xiang ^a   He, Ai Na ^a   Sun, Yuan Jue ^a   Shen, Zan ^a   Yao, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Immunohistochemical; Meta analysis; Prognosis; Survivin

Indexed keywords

SURVIVIN;

ARTICLE; ASIA; CANCER PROGNOSIS; COLORECTAL CARCINOMA; DISEASE FREE INTERVAL; DISTANT METASTASIS; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; TUMOR INVASION;

COLORECTAL CARCINOMA; IMMUNOHISTOCHEMICAL; META-ANALYSIS; PROGNOSIS; SURVIVIN;

ADULT; AGED; CHINA; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84885103833     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt103     Document Type: Article

References (34)

1. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
2. Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2003;2:41.
3. Boo YJ, Park JM, Kim J, et al. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol 2007;14:1703-11.
4. Feezor RJ, Copeland EM, 3rd, Hochwald SN. Significance of micrometastases in colorectal cancer. Ann Surg Oncol 2002;9:944-53.
5. Sah NK, Khan Z, Khan GJ, Bisen PS. Structural, functional and therapeutic biology of survivin. Cancer Lett 2006;244:164-71.
6. Reed JC, Bischoff JR. BIRinging chromosomes through cell division- and survivin' the experience. Cell 2000;102:545-8.
7. Tran J, Master Z, Yu JL, Rak J, Dumont DJ, Kerbel RS. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci USA 2002;99:4349-54.
8. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21.
9. Waligorska-Stachura J, Jankowska A, Wasko R, et al. Survivin- prognostic tumor biomarker in human neoplasms-review. Ginekol Pol 2012;83:537-40.
10. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003;3:46-54.
11. Xi RC, Biao WS, Gang ZZ. Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival. Onkologie 2011;34:428-32.
12. Sprenger T, Rodel F, Beissbarth T, et al. Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival. Clin Cancer Res 2011;17:1623-31.
13. Chen WB, Cheng XB, Ding W, et al. Centromere protein F and survivin are associated with high risk and a poor prognosis in colorectal gastrointestinal stromal tumours. J Clin Pathol 2011;64:751-5.
14. Lam AK, Saleh S, Smith RA, Ho YH. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Hum Pathol 2008;39:1229-33.
15. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998;58:5071-4.
16. Ponnelle T, Chapusot C, Martin L, et al. Cellular localisation of survivin: impact on the prognosis in colorectal cancer. J Cancer Res Clin Oncol 2005;131:504-10.
17. Hernandez JM, Farma JM, Coppola D, et al. Expression of the antiapoptotic protein survivin in colon cancer. Clin Colorectal Cancer 2011;10:188-93.
18. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
22. Xiaoyuan C, Longbang C, Jinghua W, et al. Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer. Ir J Med Sci 2010;179:327-35.
23. Kalliakmanis JG, Kouvidou C, Latoufis C, et al. Survivin expression in colorectal carcinomas: correlations with clinicopathological parameters and survival. Dig Dis Sci 2010;55:2958-64.
24. Qi G, Tuncel H, Aoki E, et al. Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol Rep 2009;22:557-62.
25. Lee YY, Yu CP, Lin CK, et al. Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters. Dis Markers 2009;26:9-18.
26. Fang YJ, Lu ZH, Wang GQ, et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 2009;24: 875-84.
27. Terzi C, Canda AE, Sagol O, et al. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Int J Colorectal Dis 2008;23:37-45.
28. Abd El-Hameed A. Survivin expression in colorectal adenocarcinoma using tissue microarray. J Egypt Natl Canc Inst 2005;17:42-50.
29. Rodel F, Hoffmann J, Grabenbauer GG, et al. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Strahlenther Onkol 2002;178:426-35.
30. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 2000;46:645-50.
31. Huang LN, Wang DS, Chen YQ, et al. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies. Mol Biol Rep 2013;40:917-24.
32. Li C, Li Z, Zhu M, et al. Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis. PLoS One 2012;7:e44764.
33. Xia Y, Liu YL, Yang KH, Chen W. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review. Chin J Cancer 2010;29:441-6.
34. Lee CW, Simin K, Liu Q, et al. A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res 2008; 10:R97.